1. Home
  2. STKE vs PLUR Comparison

STKE vs PLUR Comparison

Compare STKE & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STKE

Sol Strategies Inc.

HOLD

Current Price

$1.64

Market Cap

38.3M

Sector

N/A

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

N/A

Current Price

$2.49

Market Cap

36.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STKE
PLUR
Founded
2002
2001
Country
Canada
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
36.3M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
STKE
PLUR
Price
$1.64
$2.49
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
281.9K
10.8K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.78
EPS
N/A
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
$552.94
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
309.82
52 Week Low
$0.85
$2.22
52 Week High
$7.75
$5.96

Technical Indicators

Market Signals
Indicator
STKE
PLUR
Relative Strength Index (RSI) 50.63 32.16
Support Level $1.08 N/A
Resistance Level $1.75 $3.49
Average True Range (ATR) 0.24 0.31
MACD -0.03 -0.12
Stochastic Oscillator 15.10 16.07

Price Performance

Historical Comparison
STKE
PLUR

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: